Keith Alcorn, July 24, 2019. Treatment with dolutegravir resulted in weight gain for participants in two large clinical trials in sub-Saharan Africa and was especially pronounced when dolutegravir was combined with the new formulation of tenofovir (tenofovir alafenamide fumarate, TAF), Dr. Michelle Moorhouse of the Wits Reproductive Health Institute, Johannesburg, […]
Dolutegravir leads to weight gain in two African studies Read More »
In Latin America, members of sexual minorities living with HIV suffer doubly. Experts warn that if their stigmatization does not end, the AIDS epidemic cannot be overcome in the region. The tenth World Scientific Conference on HIV (IAS 2019), which began last Sunday (July 21, 2019) in Mexico City,
IAS 2019: The stigma of AIDS exacerbates the epidemic Read More »
JULY 24, 2019 by NIH / National Institute of Allergy and Infectious Diseases A woman holds the dapivirine vaginal ring. Credit: Andrew Loxley, International Microbicides Association According to a statistical model, in an open-label study of women in southern and eastern Africa, it was estimated that a vaginal ring that is inserted
Use of vaginal ring for HIV prevention in an open-label study Read More »
July 24, 2019 | MICHAELA FLEMING People living with HIV who suffer from chronic pain are often treated with chronic opioid therapy. With such a high prevalence of chronic pain among people living with HIV (PLWH), providers sometimes deviate from prescribing guidelines.
The promising HIV vaccine will be tested on gay men and transgender people. Susan Buchbinder presenting at IAS 2019. Photo by Liz Highleyman. Liz Highleyman Published: July 22, 2019 A new Phase III HIV vaccine trial will soon be conducted on men who have sex with men and transgender people.
THE SEARCH FOR AN HIV PREVENTION VACCINE Read More »
Specialists pointed out that the migration generated by the crisis could create a problem for the health systems of transit countries, such as Mexico and Chile. Share this news. Specialists pointed out that Latin America is at risk from HIV. (Blanca Valadez) BLANCA VALADEZ Mexico City / 07/21/2019 9:04:33 PM Specialists, scientists, and activists warned about the
Crisis in Venezuela could increase HIV cases and deaths in other countries Read More »
Projecte dels Noms-Hispanosida has achieved a 68.8% reduction in HIV incidence among gay men and transgender women of Latin American origin, one of the groups most affected by the epidemic, through a combined prevention strategy implemented by its community testing center, BCN Checkpoint. BARCELONA, 22 (EUROPA PRESS) Projecte
Testing and Treatment of Sexually Transmitted Infections. Roger Pebody, July 22, 2019. The rollout of pre-exposure prophylaxis (PrEP) offers an opportunity to reduce the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programs are better coordinated and integrated, representatives of
PrEP services could improve STI control, says the World Health Organization. Read More »
Gus Cairns, July 22, 2019. The 2019 HIV and Hepatitis B Cure Forum took place from July 20-21, immediately preceding the 10th International AIDS Society Conference on HIV Science (NIC 2019) in Mexico City this week. The forum
Dolutegravir is a more effective, easier-to-take medication with fewer side effects than currently used alternative medications, and the risks of neural tube defects are significantly lower than initial studies may have suggested. Based on new evidence evaluating the benefits and risks
